Skip to main content
Premium Trial:

Request an Annual Quote

IP Watch: Abbott, Hologic, Qiagen, Others Win US Patents


Qiagen has been awarded US Patent No. 8,883,412, "Size standards for use in nucleic acid analysis."

Valerie Tucker, Pieris Koumi, Andrew Hopwood, and Keith Elliot are named as inventors.

Icon Genetics has been awarded US Patent No. 8,883,420, "Process of clean cloning."

Sylvestre Marillonnet, Stefan Werner, Carola Engler, Romy Kandzia, Frank Thieme, and Ernst Weber are named as inventors.

New England Biolabs has been awarded US Patent No. 8,883,421, "Method for reducing adapter-dimer formation."

Larry McReynolds and Daniela Munafo are named as inventors.

T2 Biosystems has been awarded US Patent No. 8,883,423, "NMR systems and methods for the rapid detection of analytes."

Lori Neely is named as the inventor.

Agilent has been awarded US Patent No. 8,883,454, "DNA polymerase fusions and uses thereof."

Michael Borns is named as the inventor.

Gen-Probe (Hologic) has been awarded US Patent No. 8,883,455, "Method for detecting the presence of a nucleic acid in a sample."

Kelly Ammann, Ralph Burns, Ernest Hansberry, Glenn Horner, Cheryl Jakub, John Kling, Donald Nieglos, Robert Schneider, and Robert Smith are named as inventors.

New England Biolabs has been awarded US Patent No. 8,883,474, "Solubilized phospholipids for stabilizing nucleic acid polymerases."

Donald Johnson and Thomas Evans are named as inventors.

Abbott has been awarded US Patent No. 8,883,487, "Molecular diagnostics system and methods."

Gordon Collier, John Wood, Jason MacLeod, William Dicke, Attila Nemeth, and Cary Miller are named as inventors.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.